Clin2
NCT03681964Possibly a fitRecruiting

Check tests for suspected Sjögren’s syndrome

Primary Sjögren's Syndrome (pSS)

Part of Immune system & allergy clinical trials.

This study follows people who have signs that might mean Sjögren’s syndrome and looks at how well a standardized work-up identifies the condition. It may help doctors confirm the diagnosis earlier and more consistently.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
100 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You have symptoms or test results that make your doctor suspect Sjögren’s syndrome.
  • You have already started (or will start) a standardized evaluation for Sjögren’s.
  • You are able and willing to go through the study process as planned.
  • You do not strongly object to joining the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05113004Recruiting· Phase 2
Testing new outcomes in primary Sjögren’s syndrome

This Phase 2 study tests how to measure changes in primary Sjögren’s syndrome symptoms and body activity. It may help researchers confirm which outcomes best reflect improvement and how different patient types respond to treatment.

Brest
NCT07642843Not yet recruiting· Phase 1
Study of CM336 for active Sjögren's syndrome

This study tests an investigational drug called CM336 for people with active Sjögren's syndrome. It aims to see if the drug is safe and effective in reducing symptoms like joint pain and dryness when other treatments haven't worked well.

Beijing, Beijing Municipality
NCT06862284Not yet recruiting· Phase 2
Upadacitinib for Sjögren's syndrome

This study tests whether upadacitinib, a pill that reduces inflammation, can help people with Sjögren's syndrome. It aims to see if the drug can lower disease activity and improve symptoms.

Beijing, China
NCT07818694Not yet recruiting· Phase 1
Study of a new injection for dryness and other Sjögren's symptoms

This study tests an investigational drug called JH013 for primary Sjögren's syndrome. It aims to reduce dryness and other symptoms like fatigue and joint pain, and may help people with moderate to severe disease activity.

NCT07852234Not yet recruiting· Phase 2
Low-dose blinatumomab for moderate to severe Sjögren's syndrome

This study tests a low-dose medication called blinatumomab, which targets certain immune cells, to see if it can help control symptoms of moderate to severe Sjögren's syndrome, especially dry eyes. It is for people who have not gotten enough relief from standard treatments.

Beijing, Beijing Municipality
NCT04931160Recruiting
Study for suspected Sjögren’s disease diagnosis

This study follows people who may have Sjögren’s disease to better understand how to diagnose it. If you have symptoms like dry eyes or dry mouth, this could help researchers confirm the diagnosis and learn what tests best explain it.

Brest

Hear when a new Primary Sjögren's Syndrome (pSS) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.